Antibiotic Therapy for Cholangitis

Treatment Duration and Algorithm

For immunocompetent patients with mild cholangitis who achieve adequate biliary drainage, antibiotics should be administered for 4 days after source control is established, as recommended by the American College of Physicians 1
Up to 7 days of antibiotics should be administered for immunocompromised or critically ill patients, even with adequate source control, according to the Infectious Diseases Society of America 1
The 2010 SIS/IDSA guidelines recommend discontinuing antibiotics within 24 hours for cholecystitis unless infection extends beyond the gallbladder wall 2

Biliary drainage is absolutely mandatory and represents the cornerstone of treatment—antibiotics alone without drainage result in therapeutic failure, as stated by the American College of Surgeons 1
Patients with persistent obstruction or incomplete drainage require additional drainage procedures, not simply prolonged antibiotics, as recommended by the Society of Surgical Oncology 1

Amoxicillin integral/clavulanate 2g/0.2g every 8 hours is recommended as a first-line treatment for non-critical immunocompetent patients, according to the American College of Physicians 1
Piperacillin/tazobactam provides adequate anaerobic coverage and is an alternative option, as suggested by the European Association for the Study of the Liver 3
Third-generation cephalosporins with anaerobic coverage are recommended for severe cases or healthcare-associated infections, as stated by the Infectious Diseases Society of America 3

Enterococcal coverage is not routinely required for community-acquired biliary infection, as recommended by the American College of Physicians 2
Anaerobic coverage is not indicated unless a biliary-enteric anastomosis is present, according to the Society of Surgical Oncology 2, 1
Fungal infections, such as Candida, are associated with poor prognosis and often indicate advanced disease, as stated by the European Association for the Study of the Liver 3

Never continue antibiotics beyond 7 days without investigating for complications or alternative diagnoses, as recommended by the American College of Physicians 1, 4
Avoid fluoroquinolones as first-line agents due to high resistance rates and unfavorable side effects, as suggested by the European Association for the Study of the Liver 3
Avoid empiric vancomycin-resistant Enterococcus coverage unless the patient is at very high risk, as recommended by the Infectious Diseases Society of America 2

Adjust antibiotic duration according to clinical response and laboratory markers, as recommended by the American College of Physicians 1
Tailor treatment to local epidemiology, risk factors for multidrug-resistant bacteria, and infection severity, as suggested by the European Association for the Study of the Liver 3
Obtain biliary cultures in cases of recurrent cholangitis requiring long-term or rotating antibiotics, as recommended by the European Association for the Study of the Liver 3